- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: relapsed multiple myeloma
Total 17204 results
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Japan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Multiple Myeloma-Light Chain OnlyUnited States
-
AbbVieTerminatedCancer | Multiple Myeloma (MM)United States, Australia, France, Israel, Japan, Spain, Taiwan
-
Bristol-Myers SquibbCompleted
-
AbbVieCelgeneTerminatedMultiple MyelomaUnited States, Spain, United Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Recurrent Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Plasma Cell Myeloma | Myeloproliferative Neoplasm | Recurrent... and other conditionsUnited States
-
Taiho Oncology, Inc.TerminatedMultiple Myeloma | NonHodgkin LymphomaUnited States
-
RedHill Biopharma LimitedNational Cancer Institute (NCI); Duke University; Apogee Biotechnology CorporationTerminatedMultiple MyelomaUnited States
-
Ohio State University Comprehensive Cancer CenterCelgeneCompletedRecurrent Plasma Cell MyelomaUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
GlaxoSmithKlineCompletedNeoplasmsSpain, United States, Korea, Republic of, United Kingdom, Australia
-
National Cancer Institute (NCI)TerminatedMyeloma, Multiple | Myeloma-MultipleUnited States
-
AmgenTerminated
-
University of ArkansasCelgeneCompletedMultiple MyelomaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Chinook Therapeutics, Inc.TerminatedMultiple MyelomaUnited States
-
Oncopeptides ABApproved for marketingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Sun Yat-sen UniversityUnknownRelapsed, Refractory, Multiple MyelomaChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedFatigue | Anemia | Weight Loss | Thrombocytopenia | Fever | Refractory Plasma Cell Myeloma | Lymphadenopathy | Refractory Chronic Lymphocytic Leukemia | Recurrent Plasma Cell Myeloma | Splenomegaly | Recurrent Chronic Lymphocytic Leukemia | Lymphocytosis | Night SweatsUnited States
-
National Cancer Institute (NCI)TerminatedStage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
PETHEMA FoundationCompletedRelapsed and Refractory Multiple MyelomaSpain
-
Boston VA Research Institute, Inc.Celgene Corporation; Edward Hines Jr. VA Hospital; Michael E. DeBakey VA Medical... and other collaboratorsCompletedMultiple MyelomaUnited States
-
Association for Training, Education, and Research...CompletedRelapsed Multiple MyelomaFrance
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
AmgenTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaUnited States, Turkey, Canada, Netherlands, Australia, Germany, France
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Novartis PharmaceuticalsCompletedMultiple MyelomaUnited States, Germany, Spain, Singapore
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Novartis PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Karyopharm Therapeutics IncCompletedMultiple Myeloma | Relapsed and/or Refractory Multiple MyelomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedRecurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
The Sixth Affiliated Hospital of Wenzhou Medical...Zhejiang Qixin BiotechUnknown
-
Merck Sharp & Dohme LLCCompletedRelapsed or Refractory Multiple Myeloma
-
Janssen Research & Development, LLCCompleted
-
Case Comprehensive Cancer CenterCompletedRefractory Multiple MyelomaUnited States
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
Universitaire Ziekenhuizen KU LeuvenWithdrawnHematologic Diseases | Multiple MyelomaBelgium
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Oncopeptides ABTerminatedRelapsed and/or Relapsed-refractory Multiple MyelomaUnited States, Netherlands, Denmark, Sweden, Italy
-
Autolus LimitedTerminatedMultiple MyelomaUnited Kingdom, Netherlands
-
Parameswaran HariCompletedMultiple MyelomaUnited States
-
PfizerCompletedAdvanced Multiple MyelomaGermany, United States, Spain, United Kingdom, Belgium, Canada, France, Greece
-
PfizerCompletedMultiple Myeloma | Plasma Cell LeukemiaUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...CARsgen Therapeutics Co., Ltd.Active, not recruitingRefractory or Relapsed Multiple MyelomaChina
-
First Affiliated Hospital of Zhejiang UniversityCARsgen Therapeutics Co., Ltd.Active, not recruitingRefractory or Relapsed Multiple MyelomaChina
-
Array Biopharma, now a wholly owned subsidiary...CompletedMultiple Myeloma, Plasma Cell LeukemiaUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Yanda Ludaopei Hospital; Beijing Lu Daopei HospitalUnknown
-
University Health Network, TorontoMultiple Myeloma Research ConsortiumTerminatedMultiple Myeloma | Relapsed/RefractoryCanada